SPECT and PET serve as molecular imaging techniques and in Vivo biomarkers for brain metastases

International Journal of Molecular Sciences

Volumn 15, Issue 6, 2014, Pages 9878-9893

  Palumbo, Barbara ^a   Buresta, Tommaso ^a   Nuvoli, Susanna ^b   Spanu, Angela ^b   Schillaci, Orazio ^c,d   Fravolini, Mario Luca ^a   Palumbo, Isabella ^a  

^a UNIVERSITY OF PERUGIA   (Italy)

^b UNIVERSITY OF SASSARI   (Italy)

^c UNIVERSITY OF ROME TOR VERGATA   (Italy)

^d IRCCS NEUROMED   (Italy)

Author keywords

Brain metastases; Fusion imaging; Molecular imaging; MRI; PET; SPECT

Indexed keywords

2 (2 18F FLUOROETHYL) LEVO TYROSINE; 3' FLUOROTHYMIDINE F 18; 6 FLUORODOPA F 18; CARBON 11; CHOLINE DERIVATIVE; FLUORINE 18; FLUORODEOXYGLUCOSE F 18; GADOLINIUM; METHIONINE C 11; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; NITROGEN 13; OXYGEN 15; RADIOPHARMACEUTICAL AGENT; TETROFOSMIN TC 99M; THALLIUM CHLORIDE TL 201; THYMIDINE KINASE 1; UNCLASSIFIED DRUG; TUMOR MARKER;

BLOOD BRAIN BARRIER; BRAIN METASTASIS; BRAIN TUMOR; DIFFUSION WEIGHTED IMAGING; DOSIMETRY; HUMAN; INTENSITY MODULATED RADIATION THERAPY; LUNG CANCER; LUNG NON SMALL CELL CANCER; MOLECULAR IMAGING; MULTIMODALITY CANCER THERAPY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PERFUSION WEIGHTED IMAGING; PET-CT SCANNER; POSITRON EMISSION TOMOGRAPHY; PREDICTIVE VALUE; RADIATION NECROSIS; RECEIVER OPERATING CHARACTERISTIC; REVIEW; SENSITIVITY AND SPECIFICITY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STEREOTACTIC RADIOSURGERY; TUMOR VOLUME; ANIMAL; BRAIN; BRAIN NEOPLASMS; PATHOLOGY; PROCEDURES; SECONDARY;

ANIMALS; BIOMARKERS, TUMOR; BRAIN; BRAIN NEOPLASMS; HUMANS; MOLECULAR IMAGING; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 84901951708     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms15069878     Document Type: Review

References (44)

1. Lucignani, G.; Bombardieri, E. Molecular imaging: Seeing the invisible beyond the "hot spot". Q. J. Nucl. Med. Mol. Imaging 2004, 48, 1-3.
2. 18F-fluoroethyl)-L-tyrosine PET as a diagnostic tool for detection of malignant progression in patients with low-grade glioma. J. Nucl. Med. 2013, 54, 2046-2054.
3. Palumbo, B. Brain tumour recurrence: Brain single-photon emission computerized tomography, PET and proton magnetic resonance spectroscopy. Nucl. Med. Commun. 2008, 29, 730-735.
4. Kickingereder, P.; Dorn, F.; Blau, T.; Schmidt, M.; Kocher, M.; Galldiks, N.; Ruge, M.I.; Differentiation of local tumor recurrence from radiation-induced changes after stereotactic radiosurgery for treatment of brain metastasis: Case report and review of the literature. Radiat. Oncol. 2013, 8, 52.
5. Benard, F.; Romsa, J.; Hustinx, R. Imaging gliomas with positron emission tomography and single-photon emission computed tomography. Semin. Nucl. Med. 2003, 33, 148-162.
6. Minn, H. PET and SPECT in low-grade glioma. Eur. J. Radiol. 2005, 56, 171-178.
7. Lee, H.Y.; Chung, J.K.; Jeong, J.M.; Lee, D.S.; Kim, D.G.; Jung, H.W.; Lee, M.C. Comparison of FDG-PET findings of brain metastasis from non-small-cell lung cancer and small-cell lung cancer. Ann. Nucl. Med. 2008, 22, 281-286.
8. 18F-FDG-PET/CT for diagnosis in the initial staging. Nuklearmedizin 2011, 50, 101-106.
9. Wang, S.X.; Boethius, J.; Ericson, K. FDG-PET on irradiated brain tumor: Ten years' summary. Acta Radiol. 2006, 47, 85-90.
10. Horky, L.L.; Hsiao, E.M.; Weiss, S.E.; Drappatz, J.; Gerbaudo, V.H. Dual phase FDG-PET imaging of brain metastases provides superior assessment of recurrence versus post-treatment necrosis. J. Neurooncol. 2011, 103, 137-146.
11. 18F-FDG PET of common enhancing malignant brain tumors. Am. J. Roentgenol. 2008, 190, W365-W369.
12. Palumbo, B.; Angotti, F.; Marano, G.D. Relationship between PET-FDG and MRI apparent diffusion coefficients in brain tumors. Q. J. Nucl. Med. Mol. Imaging 2009, 53, 17-22.
13. Stanescu, L.; Ishak, G.E.; Khanna, P.C.; Biyyam, D.R.; Shaw, D.W.; Parisi, M.T. FDG PET of the brain in pediatric patients: Imaging spectrum with MR imaging correlation. Radiographics 2013, 33, 1279-1303.
14. 11C]choline PET/CT in patients with biochemical failure after radical prostatectomy. Eur. J. Nucl. Med. Mol. Imaging 2010, 37, 301-309.
15. 18F-Choline PET/CT pitfalls in image interpretation: An update on 300 examined patients with prostate cancer. Clin. Nucl. Med. 2014, 39, 122-130.
16. Treglia, G.; Giovannini, E.; di, F.D.; Calcagni, M.L.; Rufini, V.; Picchio, M.; Giordano, A. The role of positron emission tomography using carbon-11 and fluorine-18 choline in tumors other than prostate cancer: A systematic review. Ann. Nucl. Med. 2012, 26, 451-461.
17. 11C-choline PET/CT for their potentials in differentiating brain tumor recurrence from brain tumor necrosis following radiotherapy. Clin. Nucl. Med. 2011, 36, 978-981.
18. 11C-CHO PET in optimization of target volume delineation and treatment regimens in postoperative radiotherapy for brain gliomas. Nucl. Med. Biol. 2012, 39, 437-442.
19. 18F-labelled fluoromethylcholine: A dynamic positron emission tomography study. Nucl. Med. Commun. 2012, 33, 954-959.
20. Rottenburger, C.; Hentschel, M.; Kelly, T.; Trippel, M.; Brink, I.; Reithmeier, T.; Meyer, P.T.; Nikkhah, G. Comparison of C-11 methionine and C-11 choline for PET imaging of brain metastases: A prospective pilot study. Clin. Nucl. Med. 2011, 36, 639-642.
21. Miyagawa, T.; Oku, T.; Uehara, H.; Desai, R.; Beattie, B.; Tjuvajev, J.; Blasberg, R. "Facilitated" amino acid transport is upregulated in brain tumors. J. Cereb. Blood Flow Metab. 1998, 18, 500-509.
22. Laverman, P; Boerman, O.C.; Corstens, F.H.; Oyen, W.J. Fluorinated amino acids for tumour imaging with positron emission tomography. Eur. J. Nucl. Med. Mol. Imaging 2002, 29, 681-690.
23. Chen, W. Clinical applications of PET in brain tumors. J. Nucl. Med. 2007, 48, 1468-1481.
24. 11C-methionine PET in imaging brain tumours and metastases. Eur. J. Nucl. Med. Mol. Imaging 2013, 40, 615-635.
25. 11C-methionine PET on expected management of patients with brain neoplasm. Eur. J. Nucl. Med. Mol. Imaging 2010, 37, 685-690.
26. 18F]fluoroethyl)-L-tyrosine (FET) uptake in human tumour and inflammatory cells. Eur. J. Nucl. Med. Mol. Imaging 2006, 33, 932-939.
27. 11C-methionine PET for differentiation of recurrent brain tumors from radiation necrosis after radiotherapy. J. Nucl. Med. 2008, 49, 694-699.
28. 11C]methionine (MET)-PET in patients with brain gliomas and metastases. Int. J. Radiat. Oncol. Biol.Phys. 2011, 81, 1049-1058.
29. Miwa, K.; Matsuo, M.; Shinoda, J.; Aki, T.; Yonezawa, S.; Ito, T.; Asano, Y.; Yamada, M.; Yokoyama, K.; Yamada, J. et al. Clinical value of [11C]methionine PET for stereotactic radiation therapy with intensity modulated radiation therapy to metastatic brain tumors. Int. J. Radiat. Oncol. Biol. Phys. 2012, 84, 1139-1144.
30. 11C-methionine-PET for the radiotherapy of brain metastases. Int. J. Radiat. Oncol. Biol. Phys. 2009, 74, 714-722.
31. 11C-methionine PET. Radiother. Oncol. 2008, 89, 270-277.
32. 1H-MRS) to assess glioma recurrence after radiotherapy. Q. J. Nucl. Med. Mol. Imaging 2006, 50, 88-93.
33. 18F-DOPA PET and biodistribution in gliomas for neurosurgical planning and radiotherapy target delineation: Results of a prospective pilot study. Neuro Oncol. 2013, 15, 1058-1067.
34. 18F-DOPA PET and PET/CT. Nucl. Med. Commun. 2012, 33, 563-570.
35. 18F-fluoro-L-phenylalanine PET/CT on managing patients with brain tumors: The referring physician's perspective. J. Nucl. Med. 2012, 53, 393-398.
36. 11C]methionine. Eur. J. Nucl. Med. Mol. Imaging. 2003, 30, 1561-1567.
37. 18F]FDG in the imaging of small cell lung carcinoma: Preliminary results. Eur. J. Nucl. Med. Mol. Imaging 2003, 30, 1266-1269.
38. 18F-FDOPA kinetics in brain tumors. J. Nucl. Med. 2007, 48, 1651-1661.
39. Ullrich, R.; Backes, H.; Li, H.; Kracht, L.; Miletic, H.; Kesper, K.; Neumaier, B.; Heiss, W.D.; Wienhard, K.; Jacobs, A.H. Glioma proliferation as assessed by 3'-fluoro-3'-deoxy-L-thymidine positron emission tomography in patients with newly diagnosed high-grade glioma. Clin. Cancer Res. 2008, 14, 2049-2055.
40. 18F-Fluorothymidine kinetics of malignant brain tumors. Eur. J. Nucl. Med. Mol. Imaging 2007, 34, 1003-1011.
41. 99 mTc]tetrofosmin in oncology: SPET and fusion imaging in lung cancer, malignant lymphomas and brain tumors. Q. J. Nucl. Med. Mol. Imaging 2005, 49, 133-144.
42. Kamson, D.O.; Mittal, S.; Buth, A.; Muzik, O.; Kupsky, W.J.; Robinette, N.L.; Barger, G.R.; Juhász, C. Differentiation of glioblastomas from metastatic brain tumors by tryptophan uptake and kinetic analysis: A positron emission tomographic study with magnetic resonance imaging comparison. Mol. Imaging 2013, 12, 327-337.
43. 11C-methyl-L-tryptophan PET. J. Nucl. Med. 2012, 53, 1058-1064.
44. 11C]methyl-L-tryptophan on PET in low-grade brain tumors. J. Neurooncol. 2011, 102, 409-415.